These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
859 related items for PubMed ID: 16273122
1. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells. Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C. Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122 [Abstract] [Full Text] [Related]
2. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells. Ridley DL, Rogers A, Wonnacott S. Br J Pharmacol; 2001 Aug; 133(8):1286-95. PubMed ID: 11498514 [Abstract] [Full Text] [Related]
3. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells. Peng JH, Fryer JD, Hurst RS, Schroeder KM, George AA, Morrissy S, Groppi VE, Leonard SS, Lukas RJ. J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768 [Abstract] [Full Text] [Related]
4. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine. Marks MJ, Whiteaker P, Collins AC. Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647 [Abstract] [Full Text] [Related]
5. Desensitization of neuronal nicotinic receptors of human neuroblastoma SH-SY5Y cells during short or long exposure to nicotine. Sokolova E, Matteoni C, Nistri A. Br J Pharmacol; 2005 Dec; 146(8):1087-95. PubMed ID: 16230999 [Abstract] [Full Text] [Related]
6. The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice. de Moura FB, McMahon LR. Psychopharmacology (Berl); 2017 Mar; 234(5):781-792. PubMed ID: 28028600 [Abstract] [Full Text] [Related]
7. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation. Sala M, Braida D, Pucci L, Manfredi I, Marks MJ, Wageman CR, Grady SR, Loi B, Fucile S, Fasoli F, Zoli M, Tasso B, Sparatore F, Clementi F, Gotti C. Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729 [Abstract] [Full Text] [Related]
8. Inducible, heterologous expression of human alpha7-nicotinic acetylcholine receptors in a native nicotinic receptor-null human clonal line. Peng JH, Lucero L, Fryer J, Herl J, Leonard SS, Lukas RJ. Brain Res; 1999 Apr 17; 825(1-2):172-9. PubMed ID: 10216184 [Abstract] [Full Text] [Related]
9. Mouse beta-TC6 insulinoma cells: high expression of functional alpha3beta4 nicotinic receptors mediating membrane potential, intracellular calcium, and insulin release. Ohtani M, Oka T, Badyuk M, Xiao Y, Kellar KJ, Daly JW. Mol Pharmacol; 2006 Mar 17; 69(3):899-907. PubMed ID: 16332988 [Abstract] [Full Text] [Related]
10. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization. Donnelly-Roberts DL, Puttfarcken PS, Kuntzweiler TA, Briggs CA, Anderson DJ, Campbell JE, Piattoni-Kaplan M, McKenna DG, Wasicak JT, Holladay MW, Williams M, Arneric SP. J Pharmacol Exp Ther; 1998 May 17; 285(2):777-86. PubMed ID: 9580626 [Abstract] [Full Text] [Related]
11. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine. Marks MJ, Meinerz NM, Drago J, Collins AC. Neuropharmacology; 2007 Sep 17; 53(3):390-405. PubMed ID: 17631923 [Abstract] [Full Text] [Related]
12. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists. Rao TS, Correa LD, Adams P, Santori EM, Sacaan AI. Brain Res; 2003 Nov 14; 990(1-2):203-8. PubMed ID: 14568345 [Abstract] [Full Text] [Related]
13. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors. Wu J, Liu Q, Yu K, Hu J, Kuo YP, Segerberg M, St John PA, Lukas RJ. J Physiol; 2006 Oct 01; 576(Pt 1):103-18. PubMed ID: 16825297 [Abstract] [Full Text] [Related]
14. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain. Metaxas A, Al-Hasani R, Farshim P, Tubby K, Berwick A, Ledent C, Hourani S, Kitchen I, Bailey A. Neuropharmacology; 2013 Aug 01; 71():228-36. PubMed ID: 23583933 [Abstract] [Full Text] [Related]
15. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment. Meyers EE, Loetz EC, Marks MJ. Pharmacol Biochem Behav; 2015 Mar 01; 130():1-8. PubMed ID: 25560939 [Abstract] [Full Text] [Related]
16. Role of neuronal nicotinic acetylcholine receptors (nAChRs) on learning and memory in zebrafish. Braida D, Ponzoni L, Martucci R, Sparatore F, Gotti C, Sala M. Psychopharmacology (Berl); 2014 May 01; 231(9):1975-85. PubMed ID: 24311357 [Abstract] [Full Text] [Related]